Upcoming Webinars

From January 1 to June 30, 2024, Belgium holds the presidency of the Council of the European Union. During this session we will discuss the priorities in the area of taxation and provide an overview of those tax developments that should be on your radar.

This webinar will present the latest visitor arrival forecasts to and from the Asia Pacific region, taking into account the impact of China’s recent visa waiver policy for selected countries, ongoing geopolitical conflicts, rising travel costs, and economic downturns in major source markets for the region. Scenario forecasts, consisting of mild, medium, and severe scenarios, have been developed to account for different levels of uncertainties, stemmed from the above-mentioned challenges. Participants of the webinar will be able to interact with the speakers about the latest visitor arrival forecasts, gaining valuable insights into the underlining factors that affect these forecasts.

For every $1B in spend, $2M in overpayments slip through normal ERP controls. And when companies deploy procure-to-pay technology like eInvoicing or an ERP migration, the overpayments spike…dramatically. During this session, we will walk through data-based case studies highlighting the impact on invoice processing and payments during new tech deployments. Then, we will show you how apexanalytix recovers and prevents billions of mistakes every year for our clients. Whatever initiative your team may have in 2024, an AP recovery audit can help fund your project while also identifying issues that could prevent future overpayments. Join to find out: What caused a 1600% increase in duplicate payments at a large hospitality company Everything you need to know about an AP recovery audit The ins and outs of apexanalytix’s duplicate payment prevention software Additional recovery audits to fund 2024 projects: unclaimed property, sales & use tax, contract compliance Why it is especially critical to conduct a recovery audit before and after your SAP S4 HANA cloud migration, or any system upgrade, consolidation, or new implementation.

Meeting Registration. Information you provide when registering will be shared with the account owner and host and can be used and shared by them in accordance with their Terms and Privacy Policy.

Discover a groundbreaking webinar exploring innovative approaches in the discovery of bispecific antibodies using the ATX-CLC mouse strain along with reviewing case studies and validated data. Bispecific antibodies continue to be a transformative approach to treating a wide range of diseases across a range of mechanisms including T-Cell engagers, biparatopics, cis-targeting and more. However, discovering novel, developable and therapeutically relevant bispecifics is technically and strategically challenging and requires deep domain expertise as well as next-generation, integrated workflows. Alloy Therapeutic’s bispecific discovery services integrate best-in-class discovery platform technologies with world-class scientific experts to serve as an extension of research and development (R&D) teams and take bispecific programs further faster.

Introducing a new bioanalytical technology for assessing monoclonal antibody (mAb) sample quality from early-stage candidate selection to manufacturability evaluation - mass photometry. In this webinar, you’ll discover how mass photometry can be used for forced antibody degradation assessment, a crucial aspect of research and development for recombinant mAb therapeutics. Our expert speaker will also demonstrate how mass photometry data compares to and complements the current gold standard, size exclusion chromatography (SEC), as well as providing insights into other applications of mass photometry in therapeutic antibody R&D labs. Attend this webinar to discover: - How mass photometry enables rapid assessment of sample quality - How mass photometry complements other analytical methods for antibody sample characterization, such as SEC - What the sample requirements are for detection of antibody aggregates and fragments

In this session we will go through an update on the status of the OECD work on Pillar 1 (amount A & B) and what to expect in 2024. The content we will cover will include an update on where we are in the process for amounts A & B and timelines, (ii) practical implications for business and (iii) a discussion on digital services taxes (DSTs).

What do you need to think about when decarbonising your fleet? Road transport is one of the largest contributors to the UK’s greenhouse gas emissions, amounting to around 22%. Fleets will need to make big changes to both their vehicles and operations to reach net zero. In this webinar, we have a look at what you’ll need to do and the best ways to go about it. Every fleet’s journey to decarbonisation is different. You should know what to pick and choose to improve or electrify your fleet. We’ll touch upon: • why fleet decarbonisation matters…now! • using data to your advantage • looking beyond the vehicles (including depots) • working collaboratively • grey fleets and salary sacrifice • developing the plan • Q&A About the presenter James Brown – fleet support manager James is part of the Fleet advice team at Energy Saving Trust and was a fleet manager for 14 years and since has extensive experience of reviewing fleets and recommending improvements. Reserve your place today.

In general, large pharmaceutical companies favor adopting functional service provider (FSP) models over full-service outsourcing across their clinical and research and development (R&D) operations. FSPs allow for greater oversight and can offer better outcomes regarding accelerated delivery and higher quality data. Can smaller companies benefit from working with a contract research organization (CRO) through an FSP model? During this webinar, participants will delve into the explorative realm of FSP models, particularly how to curate them for mid-sized companies to elevate their clinical trial performance.

Live webinar on Monday February 5 at noon. Information you provide when registering will be shared with the account owner and host and can be used and shared by them in accordance with their Terms and Privacy Policy.